Skip to content
Engager
  • About
  • Services
  • Work
  • Blog
  • Contact
  • Plan for Stakeholders, Not ScenariosApril 21, 2026

    You don’t build credibility in the moment. You risk it.

    In biopharma, few things are more fraught than the Phase 3 readout. Every stakeholder is watching. Investors modeling. Clinicians forming opinions. Patient advocacy organizations and families hoping for new options. The company’s own teams, from investor relations to medical affairs to marketing to market access to government affairs, are running their own parallel preparations, often without a shared view of what others are doing or what others know.

    The conventional response to that situation is scenario planning. Map the possible outcomes. Prepare statements for each. Establish a clearance process. Wait for the data.

    We took a different approach.

    Working with a global biopharma company ahead of a pivotal readout, we built an integrated stakeholder engagement plan. Not a crisis communications plan. Not a scenario-planning exercise. An engagement plan: a research-anchored assessment of eight stakeholder groups essential to the company’s long-term success, each mapped from where they stood at the start to where they needed to be by the time results were in hand, so that any outcome could be received in context rather than as a surprise.

    The plan mapped across the whole clinical development program. It included proactive engagement at every key landmark, the company’s and their stakeholders. Not announcements. Conversations and actions. Not managed messages. Shared progress.

    When the results came in and the trial outcome was negative, a coordinated plan was already in place across all eight. Not a siloed set of individual preparations. A single, integrated response built from a common foundation of stakeholder understanding.

    Even those most desperate for good news understood the outcome and held the company in high regard for bringing them along on the journey.

    That is not a communications outcome. It is a trust outcome. And it was built before the data existed.

    What Scenario Planning Gets Right, and What It Misses

    Scenario planning is a reasonable tool for managing what you say and anticipating operational choices. Readying for the unexpected, though sometimes predicted. It is not a plan for managing what your stakeholders experience.

    The distinction matters because stakeholders are not waiting for your announcement. They are forming opinions, gathering intelligence, comparing notes with each other, and building their own understanding of you and your situation based on everything they see, hear, do not hear from you and experience with you. By the time any landmark arrives, the context in which it lands has already been shaped.

    Scenario planning prepares the message and the corporate response. It does not build the relationship in which the message will be received.

    Every stakeholder audience arrives at the moment carrying assumptions, concerns, and relationship histories that no announcement can quickly undo.

    The integrated approach begins earlier. It begins with a question most organizations do not ask systematically: where does each critical stakeholder stand today, and what needs to be true about our relationship with them before the results arrive?

    What an Integrated Stakeholder Engagement Plan Actually Looks Like

    The work starts with a rigorous assessment of each stakeholder group: where are they now, in terms of understanding, confidence, and relationship with the company? What are their priorities and concerns? Who and what shapes their thinking? What are the key milestones on their own calendar that determine when they are most receptive and when they are most concerned? From that baseline, the plan maps each group forward to where they need to be, not in terms of what they believe about a specific outcome, but in terms of their relationship with the company’s science, their confidence in leadership’s judgment, and their understanding of what the program is designed to accomplish and why?

    The engagement points that connect those two positions are planned conversations, calibrated over time, that build the relationship the company will need. Every interaction is designed to move a stakeholder along a specific arc, from their current position to the one that serves both parties when the stakes are highest.

    This is not a messaging exercise. It is architecture. (Readers of Episode 2 will recognize the principle.)

    The Internal Alignment Problem Nobody Addresses Directly

    There is a second priority to this work that is rarely discussed with the directness it deserves: building organizational coordination and cross-functional capacity.

    In many organizations approaching a major milestone, investor relations, medical affairs, marketing, corporate affairs, and other functions are each running their own preparation. Each function has its own stakeholders, its own clearance requirements, its own institutional knowledge and engagement tradition. Each team is competent. Most are not coordinating.

    The result is a set of parallel preparations that converge at the same moment, the trial results and public disclosure, with different assumptions about the message, different levels of familiarity with the external stakeholder landscape, and different thresholds for what a successful response looks like. The tension in the planning war rooms is palpable because the interplay of stakeholder groups is rarely anticipated from the outset.

    Engagement by Design treats the alignment of internal functions as part of the stakeholder engagement strategy, not as a separate organizational problem to be solved later. The plan that guides communication must also be the plan that aligns internal teams and optimizes key actions. Not because internal alignment is a management virtue (though it is), but because stakeholders detect its absence. Investors talk to investigators. Patient advocates compare notes across the globe. Physicians build their expectations of a company’s current portfolio and what’s promising in the pipeline. A company that is not coordinated internally will eventually demonstrate that externally.

    Trust as a Measurable Corporate Asset

    The measure of an integrated stakeholder engagement plan is not how smoothly an announcement goes. It is the state of the relationship after an announcement, including when the news is not what anyone had hoped for.

    In the example here, stakeholders who had every reason to be disappointed by a negative trial outcome held the company in high regard. That is a specific, observable, consequential result. It reflects decisions made and actions taken months and years before the data existed. It is also the definition of what transparency looks like as a sustained corporate practice, not as a one-time gesture or a crisis communications posture.

    That reputation is not a byproduct of good work. It is the result of planned, proactive engagement, designed in advance, executed with discipline, and measured in the quality of the relationships it produces.

    The Question to Ask Before the Next Milestone

    The Impact Imperative returns to the same standard across every episode: does your engagement strategy produce evidence of impact, or only evidence of effort?

    For integrated stakeholder engagement, the questions are pointed. Do you know where each critical audience stands today, before the news arrives? Are your internal teams working from a shared understanding, or running parallel preparations that will converge at the last possible moment? When the outcome comes, whatever it is, will your stakeholders have the context to receive it, because you built that context with them over time?

    If the honest answer to any of those questions is uncertain, the architecture for sustained stakeholder engagement is worth examining before it is needed.

    That is where our work together begins.

  • Share on Mail (Opens in new window)Mail
  • Share on LinkedIn (Opens in new window)LinkedIn

Recent posts:

  • Plan for Stakeholders, Not ScenariosApril 21, 2026
    In biopharma, building stakeholder trust before a Phase 3 trial readout is crucial. Instead of traditional scenario planning, an integrated stakeholder engagement plan was implemented, fostering proactive conversations to enhance relationships. This approach ensured that even with a negative outcome, stakeholders maintained respect for the company, reflecting effective, long-term engagement strategies.
  • Discipline 2: Establish a Clear Narrative ArcApril 7, 2026
    Structure isn’t decoration. It’s the argument. Early in almost every client engagement, I ask the same question: can I see your corporate narrative? What arrives next is reliable. A flurry of analyst reports. A deck or two. Messaging documents. Perhaps… Read more: Discipline 2: Establish a Clear Narrative Arc
  • Discipline 1: Understand Your Audience is Key to Effective EngagementMarch 30, 2026
    The engagement that never moves anyone doesn’t count. In a room of health policy advocates, someone posed a difficult scenario: how would you respond if a critical category of funding were eliminated by an ill-conceived policy proposal? One leader’s response… Read more: Discipline 1: Understand Your Audience is Key to Effective Engagement
  • Engaging Patients: Skills for Better Healthcare DecisionsFebruary 16, 2026
    Here’s what I believe: engagement isn’t just about getting people to use a portal or download an app. It’s about building genuine health literacy and decision-making skills over time. It’s about creating systems that meet people where they are—not where… Read more: Engaging Patients: Skills for Better Healthcare Decisions
  • JPM26 in Summary: Fat and Mostly HappyJanuary 14, 2026
    Another January, another pilgrimage to San Francisco for the biotech industry’s annual reckoning. This year’s JP Morgan Healthcare Conference delivered sunny skies—a rarity that felt almost prophetic for an industry finally emerging from its brutal 2023-2024 slump. But while the… Read more: JPM26 in Summary: Fat and Mostly Happy

All entries:

  • 04.21.2026

    Plan for Stakeholders, Not Scenarios

  • 04.07.2026

    Discipline 2: Establish a Clear Narrative Arc

  • 03.30.2026

    Discipline 1: Understand Your Audience is Key to Effective Engagement

  • 02.16.2026

    Engaging Patients: Skills for Better Healthcare Decisions

  • 01.14.2026

    JPM26 in Summary: Fat and Mostly Happy

  • 12.26.2025

    2026 Predictions: The Future of Health Care and Trust

  • 11.25.2025

    Strategic Engagement: Restoring Faith in Science and Medicine

  • 10.08.2025

    Doctors, Employers and Trust in Healthcare

  • 09.21.2025

    From Disparities to Equity

  • 09.15.2025

    Myths, Facts and Health

Engager
  • Email
  • LinkedIn
  • Subscribe Subscribed
    • engagerco.com
    • Already have a WordPress.com account? Log in now.
    • engagerco.com
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar

Notifications